Immunogenicity of a contiguous T-B synthetic epitope of the A/PR/8/34 influenza virus

Journal of Virology

Volumn 71, Issue 7, 1997, Pages 5473-5480

  Brumeanu, Teodor D ^a   Casares, Sofia ^a   Bot, Adrian ^a   Bot, Simona ^a   Bona, Constantin A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; HEMAGGLUTININ; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN PRESENTING CELL; ANTIGENICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA VIRUS; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0030972162     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.7.5473-5480.1997     Document Type: Article

References (36)

1. Allan, W., Z. Tabi, A. Clearly, and P. C. Doherty. 1990. Cellular events in the lymph node and lung of mice infected with influenza. Consequences of depleting CD4+ T cells. J. Immunol. 144:3980-3986.
2. Arnon, R., E. Maron, M. Sela, and C. B. Anfinsen. 1971. Antibodies reactive with native lysozyme elicited by a completely synthetic antigen. Proc. Natl. Acad. Sci. USA 68:1450-1455.
3. Babbitt, B. P., P. M. Allen, G. Matuseda, G. Haber, and E. R. Unanue. 1985. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature (London) 31:359-361.
4. Bernatowicz, M. S., and G. R. Matsueda. 1986. Preparation of peptide-protein immunogens using N-succinimidyl bromoacetate as a heterobifunctional crosslinking reagent. Anal. Biochem. 155:95-102.
5. Billeta, R., M. R. Hollingdale, and M. Zanetti. 1991. Immunogenicity of an engineered internal antibody. Proc. Natl. Acad. Sci. USA 88:4713-4717.
6. Boons, G. J. P. H., P. Hogerhout, J. T. Poolman, G. A. van der Marel, and J. H. van Boom. 1991. Preparation of a well-defined sugar-peptide conjugate: a possible approach to synthetic vaccine against Neisseria meningitidis. Org. Med. Chem. Lett. 1:303-308.
7. Bot, A., S. Bot, S. Antohi, K. Karjalainen, and C. A. Bona. 1996. Kinetics of generation and persistence of membrane class II molecules of a viral peptide expressed on foreign and self proteins. J. Immunol. 157:3436-3442.
8. Brumeanu, T.-D., P. Dehazya, I. Wolf, and C. A. Bona. 1995. Enzymatically mediated, glycosidic conjugation of immunoglobulins with viral epitopes. J. Immunol. Methods 183:185-197.
9. Brumeanu, T.-D., H. Zaghouani, P. Dehazya, I. Wolf, A. Bot, and C. A. Bona. 1996. Engineering of doubly antigenized immunoglobulins expressing T and B viral epitopes. Immunotechnology 2:85-95.
10. Brumeanu, T.-D., R. Kohanski, C. A. Bona, and H. Zaghouani. 1993. A sensitive method to detect defined peptide among those eluted from MHC class II molecules. J. Immunol. Methods 160:65-71.
11. Brumeanu, T.-D., S. Casares, P. E. Harris, P. Dehazya, I. Wolf, and C. A. Bona. 1996. Immunopotency of a viral peptide assembled on the carbohydrate moieties of immunoglobulins. Nat. Biotechnol. 14:722-725.
12. Caton, A. J., G. C. Brownlee, J. W. Yewdell, and W. V. Gerhard. 1982. The antigenic structure of the influenza virus A/PR8/34 hemagglutinin (H1 subtype). Cell 31:417-427.
13. Deres, K., H. Schild, K.-H. Wiesmüller, G. Jung, and H.-G. Rammensee. 1989. In vivo priming of virus-specific cytotoxic T-lymphocytes with synthetic lipopeptide vaccine. Nature (London) 342:561-564.
14. DiMarchi, R., G. Broocke, C. Gale, V. Cracknell, T. Doel, and N. Mowat. 1986. Protection of cattle against foot and mouth disease by a synthetic peptide. Science 232:639-641.
15. Etlinger, H. M., E. P. Heimer, A. Trzeciak, A. M. Felix, and D. Gillessen. 1988. Assessment in mice of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, P. falciparum. Immunology 64:551-558.
16. Fiering, S., J. P. Northrop, G. P. Nolan, P. S. Mattila, G. R. Crabtree, and L. A. Herzenberg. 1990. Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T cell receptor. Genes Dev. 4:1823-1834.
17. Haberman, A. M., C. Moller, D. McCreedy, and W. V. Gerhard. 1990. A large degree of functional diversity exists among helper T cells specific for the same antigenic site of influenza hemagglutinin. J. Immunol. 145:3087-3094.
18. Herrington, D. A., D. F. Clyde, G. Losonsky, M. Cortesia, F. R. Murphy, and J. Davis. 1987. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature (London) 328:257-259.
19. Jacob, C. O., R. Arnon, and M. Sela. 1985. Effect of carrier on the immunogenic capacity of synthetic cholera vaccine. Mol. Immunol. 22:1333-1339.
20. Kirberg, J., A. Baron, S. Jacob, A. Rolink, K. Karjalainen, and H. von Boehmer. 1994. Thymic selection of CD8 single positive cells with a major histocompatibility complex-restricted receptor. J. Exp. Med. 180:25-34.
21. Liu, F. T., M. Zinnecker, T. Hamaoka, and D. H. Katz. 1979. New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino-acids and immunochemical characterization of such conjugates. Biochemistry 18:690-697.
22. Lu, Y. A., P. Clavijo, M. Galantino, Z. Y. Shen, W. Liu, and J. P. Tam. 1991. Chemically anambiguous peptide immunogen: preparation, orientation and antigenicity of purified peptide conjugated to the multiple antigen peptide system. Mol. Immunol. 28:623-630.
23. Manivel, W., R. Ramesh, S. K. Panda, and K. V. S. Rao. 1992. A synthetic peptide spontaneously self-assembles to reconstruct a group specific, conformational determinant of hepatitis B surface antigen. J. Immunol. 148: 4006-4011.
24. Means, G. E., and R. E. Feeney. 1990. Chemical modification of proteins: history and applications. Bioconjugate Chem. 1:2-10.
25. Mossman, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
26. Nolan, G. P., S. Fiering, J.-F. Nicolas, and L. A. Herzenberg. 1988. Fluorescence-activated cell analysis and sorting of viable mammalian cells based on β-galactosidase activity after transduction of Escherichia coli LacZ. Proc. Natl. Acad. Sci. USA 85:2603-2608.
27. Robey, F. A., and R. L. Fields. 1989. Automated synthesis of N-bromoacetyl-modified peptides for the preparation of synthetic peptide polymers, peptide-protein conjugates and cyclic peptides. Anal. Biochem. 177:373-377.
28. Steller, H. 1995. Mechanisms and genes of cellular suicide. Science 267: 1445-1449.
29. Sutcliffe, J. G., T. M. Shinnick, N. Green, and R. Lerner. 1983. Antibodies that react with predetermined sites on proteins. Science 219:660-666.
30. Tam, J. P. 1988. Synthetic peptide vaccine design: synthesis and properties of a high density multiple antigen peptide system. Proc. Natl. Acad. Sci. USA 85:660-666.
31. Tam, J. P., and Y. A. Lu. 1989. Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T-and B-cell epitopes. Proc. Natl. Acad. Sci. USA 86:9084-9088.
32. Tam, J. P., P. Clavijo, Y. A. Lu, V. Nussenzweig, R. Nussenzweig, and F. Zavala. 1990. Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J. Exp. Med. 171:299-306.
33. Usuba, O., J. Schulman, M. A. Dealty, C. A. Bona, and T. Moran. 1990. New method for titration of virus infectivity by immunostaining. Viral Immunol. 3:237-241.
34. Walter, G., K. Scheidtman, A. Carbone, A. P. Laudano, and R. F. Doolittle. 1980. Antibodies specific for the carboxy-and amino terminal regions of simian virus 40 large tumor antigen. Proc. Natl. Acad. Sci. USA 77:5197-5201.
35. Wiesmüller, K.-H., G. Jung, D. Gillessen, C. Loffl, W. G. Bessler, and T. Böltz. 1991. The antibody response in BALB/c mice to the plasmodium falciparum circumsporozoite repetitive epitope covalently coupled to synthetic lipopeptide adjuvant. Immunology 72:109-113.
36. Zaghouani, H., R. M. Steinman, R. Nonacs, H. Shah, W. Gerhard, and C. Bona. 1993. Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule. Science 259:224-227.